GlassScriptPhysician profile
James Bennett Soldano
NPI 1356377345
$6,957.38
in general payments reported to CMS, 2019-2025
58 companies · $256 in 2025
The $256 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,396 · 2020: $1,646 · 2021: $1,947 · 2022: $288 · 2023: $363 · 2024: $61.46 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $680.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $947.63 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $572.26 | 2019-2021 | |
| Pfizer INC. | $537.11 | 2019-2023 | |
| Abbvie INC. | $435.62 | 2019-2023 | Ubrelvy |
| Glaxosmithkline, LLC. | $314.38 | 2019-2023 | Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $301.81 | 2019-2022 | |
| Amarin Pharma, INC. | $299.74 | 2019-2021 | |
| Amgen INC. | $239.34 | 2019-2023 | Prolia, Evenity |
| Janssen Pharmaceuticals, INC | $233.41 | 2019-2022 | |
| Lilly USA, LLC | $216.80 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $215.39 | 2019-2021 | |
| Insulet Corporation | $197.55 | 2021-2025 | Omnipod |
| Exact Sciences Corporation | $196.03 | 2023-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $184.87 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $170.29 | 2019-2020 |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Soldano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.